The economic consequences of diabetes and cardiovascular disease in the United States

  • Miguel A. Ariza
  • Varsha G. Vimalananda
  • James L. Rosenzweig
Article

DOI: 10.1007/s11154-010-9128-2

Cite this article as:
Ariza, M.A., Vimalananda, V.G. & Rosenzweig, J.L. Rev Endocr Metab Disord (2010) 11: 1. doi:10.1007/s11154-010-9128-2

Abstract

Diabetes-related care and complications constitute a significant proportion of the United States’ (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates translate to higher costs of care in patients with diabetes compared to those who do not have the disease. Minorities bear a disproportionate burden of diabetes and CVD. We review this disparity and examine potential etiologies for it in Hispanics and African-Americans, the two largest minority groups in the US. We examine strategies in these populations that may improve outcomes in diabetes and CVD, potentially decreasing health care costs.

Keywords

Diabetes Cardiovascular disease Economic costs Disparities Minorities Underserved ethnic populations Costs Comorbidities 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Miguel A. Ariza
    • 1
  • Varsha G. Vimalananda
    • 1
  • James L. Rosenzweig
    • 1
  1. 1.Section of Endocrinology, Diabetes and Nutrition, Department of MedicineBoston University School of MedicineBostonUSA

Personalised recommendations